Squalamine: A Polyvalent Drug of the Future?

Author(s): Jean Michel Brunel, Chanaz Salmi, Celine Loncle, Nicolas Vidal, Yves Letourneux

Journal Name: Current Cancer Drug Targets

Volume 5 , Issue 4 , 2005

Become EABM
Become Reviewer
Call for Editor


The purpose of this mini-review is to summarize and highlight the different advances in our understanding of the antimicrobial and antiangiogenic activity of squalamine, a cationic steroid isolated in 1993 from the dogfish shark Squalus Acanthias. Indeed, squalamine has shown to be useful for the treatment of important diseases such as cancers (lung, ovarian, brain and others), age-related macular degeneration (AMD) and the control of body weight in man. All these results led to a question: could we consider squalamine as a polyvalent drug of the future?

Keywords: squalamine, aminosterol, cancer, age-related macular degeneration (amd), appetite suppression, weight reduction

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [267 - 272]
Pages: 6
DOI: 10.2174/1568009054064642
Price: $65

Article Metrics

PDF: 8